Vulnerabilities · 2016 · Smiths-medical
CVE-2016-8355
Smiths-medical Cadd-solis Medication Safety Software vulnerability
An issue was discovered in Smiths-Medical CADD-Solis Medication Safety Software, Version 1.0; 2.0; 3.0; and 3.1. CADD-Solis Medication Safety Software grants an authenticated user elevated privileges on the SQL database, which would allow an authenticated user to modify drug libraries, add and delete users, and change user permissions. According to Smiths-Medical, physical access to the pump is required to install drug library updates.
Affected products
Cadd-solis Medication Safety Software. The exact versions are in the references.
What to do now
- Check your exposureFind out whether Smiths-medical Cadd-solis Medication Safety Software runs anywhere in your environment, including systems of suppliers.
- UpdateInstall the version in which the vendor fixed the vulnerability. The references lead to the advisory.
- Set the orderSystems that can be reached from the internet come first, then the rest.
References
- www.securityfocus.com/bid/94630 · Third Party Advisory
- ics-cert.us-cert.gov/advisories/ICSMA-16-306-01 · Third Party Advisory
- nvd.nist.gov/vuln/detail/CVE-2016-8355
- cve.org/CVERecord?id=CVE-2016-8355
More vulnerabilities in Smiths-medical products
CVE-2017-12726CVE-2017-12725CVE-2017-12724CVE-2017-12723CVE-2017-12722CVE-2017-12721CVE-2017-12720CVE-2017-12718All 10
Data: CVE list and the NVD. This product uses data from the NVD API but is not endorsed or certified by the NVD.